Vis enkel innførsel

dc.contributor.authorThulin, Ingrid Viola Lavesson
dc.contributor.authorJordalen, Silje Marie Farestveit
dc.contributor.authorLekven, Ole Christian
dc.contributor.authorKrishnapillai, Jeyaseelan
dc.contributor.authorSteiro, Ole-Thomas
dc.contributor.authorCollinson, Paul
dc.contributor.authorApple, Fred
dc.contributor.authorCullen, Louise
dc.contributor.authorNorekvål, Tone Merete
dc.contributor.authorWisløff, Torbjørn
dc.contributor.authorVikenes, Kjell
dc.contributor.authorOmland, Torbjørn
dc.contributor.authorBjørneklett, Rune Oskar
dc.contributor.authorAakre, Kristin Moberg
dc.date.accessioned2024-05-08T13:14:44Z
dc.date.available2024-05-08T13:14:44Z
dc.date.created2023-11-22T17:27:01Z
dc.date.issued2023
dc.identifier.issn1401-7431
dc.identifier.urihttps://hdl.handle.net/11250/3129780
dc.description.abstractObjectives: Patients presenting with symptoms suggestive of acute coronary syndrome (ACS) contribute to a high workload and overcrowding in the Emergency Department (ED). Accelerated diagnostic protocols for non-ST-elevation myocardial infarction have proved challenging to implement. One obstacle is the turnaround time for analyzing high-sensitivity cardiac troponin (hs-cTn). In the WESTCOR-POC study (Clinical Trials number NCT05354804) we aim to evaluate safety and efficiency of a 0/1 h hs-cTn algorithm utilizing a hs-cTnI point of care (POC) instrument in comparison to central laboratory hs-cTnT measurements. Design: This is a prospective single-center randomized clinical trial aiming to include 1500 patients admitted to the ED with symptoms suggestive of ACS. Patients will receive standard investigations following the European Society of Cardiology 0/1h protocols for centralized hs-cTnT measurements or the intervention using a 0/1h POC hs-cTnI algorithm. Primary end-points are 1) Safety; death, myocardial infarction or acute revascularization within 30 days 2) Efficiency; length of stay in the ED, 3) Cost- effectiveness; total episode cost, 4) Patient satisfaction, 5) Patient symptom burden and 6) Patients quality of life. Secondary outcomes are 12-months death, myocardial infarction or acute revascularization, percentage discharged after 3 and 6 h, total length of hospital stay and all costs related to hospital contact within 12 months. Conclusion: Results from this study may facilitate implementation of POC hs-cTn testing assays and accelerated diagnostic protocols in EDs, and may serve as a valuable resource for guiding future investigations for the use of POC high sensitivity troponin assays in outpatient clinics and prehospital settings.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francisen_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleAiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain using Point of Care Testing (WESTCOR-POC): study designen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2023 the authorsen_US
dc.source.articlenumber2272585en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1080/14017431.2023.2272585
dc.identifier.cristin2200524
dc.source.journalScandinavian Cardiovascular Journalen_US
dc.identifier.citationScandinavian Cardiovascular Journal. 2023, 57 (1), 2272585.en_US
dc.source.volume57en_US
dc.source.issue1en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal